Quoin Pharmaceuticals, Ltd.: cash_and_restricted_cash
| Value | {"amount": 2860628, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | Quoin Pharmaceuticals, Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:09:31.173256+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b207b224-3fb5-4538-8df1-d7fe5991d6d4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001410578-23-000267Retrieved: 2026-08-19T17:09:31.173256+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001671502/cash-and-restricted-cash/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b207b224-3fb5-4538-8df1-d7fe5991d6d4
History
- no predecessors — first report